Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Protara Therapeutics To Give 2 Presentations And A Panel DiscussionFor The Ongoing Phase 2 Open-Label ADVANCED-2 Trial Of TARA-002 In Patients With Non-Muscle Invasive Bladder Cancer Will Be Featured At The Upcoming AUA 2025 Annual Meeting

Author: Benzinga Newsdesk | April 10, 2025 04:09pm

Posted In: TARA